Related Experiment Video
Updated: Apr 26, 2026
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
Cellular cardiomyoplasty for myocardial infarction: a 2014 evidence-based update
Alvin Nursalim1, Puspita A Katili, Teguh Santoso
1Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Insights
Stem cell therapy offers a promising new approach for repairing heart damage after myocardial infarction (MI). Future research will address challenges to enable widespread clinical application for ischemic cardiac repair.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Myocardial infarction (MI) is a leading cause of mortality globally, with many patients unresponsive to conventional therapies like reperfusion.
- Existing treatments for MI have limitations, necessitating the exploration of novel therapeutic strategies.
- Cellular cardiomyoplasty, utilizing stem cells for cardiac repair, emerges as a potential breakthrough therapy.
Purpose of the Study:
- To provide a comprehensive overview of the current advancements in stem cell therapy for myocardial infarction.
- To highlight the potential of stem cells as a therapeutic solution for salvaging damaged cardiomyocytes.
- To identify challenges and future research directions for the clinical application of stem cell therapy in cardiac repair.
Main Methods:
- Review of recent scientific literature and clinical studies on stem cell therapy for myocardial infarction.
- Analysis of the mechanisms by which stem cells promote cardiac repair.
- Evaluation of the efficacy and safety of various stem cell types in preclinical and clinical settings.
Main Results:
- Stem cells demonstrate significant potential in preclinical models for regenerating cardiac tissue and improving heart function post-MI.
- Early clinical studies suggest that stem cell transplantation can be a safe and potentially effective approach for myocardial repair.
- Ongoing research is focused on optimizing stem cell delivery, survival, and differentiation for enhanced therapeutic outcomes.
Conclusions:
- Stem cell therapy represents a promising frontier for treating myocardial infarction, offering hope for patients refractory to traditional treatments.
- Further research is crucial to overcome existing challenges, including cell engraftment, immunogenicity, and standardization of protocols.
- Successful translation of stem cell therapy could revolutionize the management of ischemic heart disease and improve patient survival and quality of life.
Abstract:
Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
01:21Myocarditis I: Introduction
01:30Cardiomyopathy II: Dilated Cardiomyopathy